RESÚMENES JUNIO 2009

.

Child & Adolescent Disorders

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3 - Transdermal methylphenidate system: old wine in a new bottle

Oscar G Bukstein

Expert Opinion on Drug Metabolism & Toxicology. June 2009, Vol. 5, No. 6, Pages 661-665

 

3! - Response to methylphenidate in children and adolescents with ADHD: does comorbid anxiety disorders matters?

Biological Child and Adolescent Psychiatry - Original Article

Response to methylphenidate in children and adolescents with ADHD: does comorbid anxiety disorders matters?

Sheila P. Garcia, Julia Guimarães, Juliana F. Zampieri, Ana Luiza Martinez, Guilherme Polanczyk and Luis Augusto Rohde

Journal of Neural Transmission. Volume 116, Number 5 / May, 2009: 631-636

 

3 - An Update on Central Nervous System Stimulant Formulations in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Benjamin Chavez, Michael A Sopko Jr., Megan J Ehret, Raphael E Paulino, Kyle R Goldberg, Kristine Angstadt, Gregory T Bogart

The Annals of Pharmacotherapy: Vol. 43, No. 6, pp. 1084-1095

 

3 - Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior. Citalopram Ineffective in Children With Autism

Bryan H. King, Eric Hollander, Linmarie Sikich, James T. McCracken, Lawrence Scahill, Joel D. Bregman, Craig L. Donnelly, Evdokia Anagnostou, Kimberly Dukes, Lisa Sullivan, Deborah Hirtz, Ann Wagner, Louise Ritz, for the STAART Psychopharmacology Network

Arch Gen Psychiatry. 2009;66(6):583-590

 

3 - Attention-Deficit–Hyperactivity Disorder: An Update

Julie A. Dopheide, Steven R. Pliszka

Pharmacotherapy. Volume: 29 | Issue: 6; June 2009: 656-679

 

3 - Aripiprazole Monotherapy in Children and Young Adolescents with Pervasive Developmental Disorders: A Retrospective Study

Masi, Gabriele; Cosenza, Angela; Millepiedi, Stefania; Muratori, Filippo; Pari, Cinzia; Salvadori, Francesco

CNS Drugs. 23(6):511-521, May 30, 2009

3 - Attention-Deficit Disorders and Epilepsy in Childhood: Incidence, Causative Relations and Treatment Possibilities

Rami Kaufmann, Hadassa Goldberg-Stern, Avinoam Shuper

Journal of Child Neurology, Vol. 24, No. 6, 727-733 (2009)

GRATIS 3! - Long-Term Safety and Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Floyd R. Sallee, Andrew Lyne, Timothy Wigal, James J. McGough

Journal of Child and Adolescent Psychopharmacology. June 2009, 19(3): 215-226

 

3 - Effects of Application to Two Different Skin Sites on the Pharmacokinetics of Transdermal Methylphenidate in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder

Mario A. González, Dawn Campbell, Jonathan Rubin

Journal of Child and Adolescent Psychopharmacology. June 2009, 19(3): 227-232

 

5 - Evaluation of Patients' and Parents' Quality of Life in a Randomized Placebo-Controlled Atomoxetine Study in Attention-Deficit/Hyperactivity Disorder

Rodrigo Escobar, Alonso Montoya, Pepa Polavieja, Esther Cardo, Josep Artigas, Amaia Hervas, Joaquín Fuentes

Journal of Child and Adolescent Psychopharmacology. June 2009, 19(3): 253-263

 

3 - Aripiprazole in Pervasive Developmental Disorder Not Otherwise Specified and Asperger's Disorder: A 14-Week, Prospective, Open-Label Study

Kimberly A. Stigler, Jonathan T. Diener, Arlene E. Kohn, Lang Li, Craig A. Erickson, David J. Posey, Christopher J. McDougle

Journal of Child and Adolescent Psychopharmacology. June 2009, 19(3): 265-274

 

3 - Metformin for Weight Control in Pediatric Patients on Atypical Antipsychotic Medication

Lauren Shin, Hallie Bregman, Janis L. Breeze, Nancy Noyes, Jean A. Frazier

Journal of Child and Adolescent Psychopharmacology. June 2009, 19(3): 275-279

 

2 - Efficacy and Safety of Fluoxetine in Preschool Children with Obsessive-Compulsive Disorder

Murat Coskun, Salih Zoroglu

Journal of Child and Adolescent Psychopharmacology. June 2009, 19(3): 297-300

 

5 - Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial

Holger Gevensleben, Birgit Holl, Björn Albrecht, Claudia Vogel, Dieter Schlamp, Oliver Kratz, Petra Studer, Aribert Rothenberger, Gunther H. Moll, and Hartmut Heinrich

Journal of Child Psychology and Psychiatry. Volume 50 Issue 7, Pages 780 - 789

 

3! - Subthreshold Depressive Disorder in Adolescents: Predictors of Escalation to Full-Syndrome Depressive Disorders

KLEIN, DANIEL N; SHANKMAN, STEWART A; LEWINSOHN, PETER M; SEELEY, JOHN R

Journal of the American Academy of Child & Adolescent Psychiatry: July 2009 - Volume 48 - Issue 7 - pp 703-710

 

3 - Relative Cost-Effectiveness of Treatments for Adolescent Depression: 36-Week Results From the TADS Randomized Trial

DOMINO, MARISA ELENA; FOSTER, E. MICHAEL; VITIELLO, BENEDETTO; KRATOCHVIL, CHRISTOPHER J; BURNS, BARBARA J; SILVA, SUSAN G; REINECKE, MARK A; MARCH, JOHN S

Journal of the American Academy of Child & Adolescent Psychiatry: July 2009 - Volume 48 - Issue 7 - pp 711-720

 

5 - Escitalopram in the Treatment of Adolescent Depression: A Randomized Placebo-Controlled Multisite Trial

EMSLIE, GRAHAM J; VENTURA, DANIEL; KOROTZER, ANDREW; TOURKODIMITRIS, STAVROS

Journal of the American Academy of Child & Adolescent Psychiatry: July 2009 - Volume 48 - Issue 7 - pp 721-729

 

3! - Positive Association Between Attention-Deficit/ Hyperactivity Disorder Medication Use and Academic Achievement During Elementary School

Richard M. Scheffler, Timothy T. Brown, Brent D. Fulton, Stephen P. Hinshaw, Peter Levine, and Susan Stone

PEDIATRICS Vol. 123 No. 5 May 2009, pp. 1273-1279

 

3! - Sudden Death and Use of Stimulant Medications in Youths

Madelyn S. Gould, B. Timothy Walsh, Jimmie Lou Munfakh, Marjorie Kleinman, Naihua Duan, Mark Olfson, Laurence Greenhill, and Thomas Cooper

Am J Psychiatry Published June 15, 2009

3! - Cardiac Safety of Methylphenidate Versus Amphetamine Salts in the Treatment of ADHD

Almut Gertrud Winterstein, Tobias Gerhard, Jonathan Shuster, and Arwa Saidi

PEDIATRICS Vol. 124 No. 1 July 2009, pp. e75-e80

 

3! - Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study

Joseph Biederman, Michael C. Monuteaux, Thomas Spencer, Timothy E. Wilens, and Stephen V. Faraone

PEDIATRICS Vol. 124 No. 1 July 2009, pp. 71-78

 

5 - Side Effects of Methylphenidate in Childhood Cancer Survivors: A Randomized Placebo-Controlled Trial

Heather M. Conklin, Joanne Lawford, Bruce W. Jasper, E. Brannon Morris, Scott C. Howard, Susan W. Ogg, Shengjie Wu, Xiaoping Xiong, and Raja B. Khan

PEDIATRICS Vol. 124 No. 1 July 2009, pp. 226-233

 

3! - Screening and Treatment for Major Depressive Disorder in Children and Adolescents: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force

PEDIATRICS Vol. 123 No. 4 April 2009, pp. 1223-1228

GRATIS Free version

 

3 - Stimulant Medications used in Children with Attention-Deficit/Hyperactivity Disorder - Communication about an Ongoing Safety Review

MedWatch - The FDA Safety Information and Adverse Event Reporting Program

Last Updated: 06/19/2009

 

GRATIS 3 (previo registro) - Pervasive Developmental Disorders and Psychosis

Jean Starling, and David Dossetor
Current Psychiatry Reports 2009, 11: (3) 190-196

.

Regresar a RESÚMENES JUNIO 2009

.

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.